27 h. ago Ozempic maker to slash 9,000 jobs globally as competition intensifies

Novo Nordisk’s plans would result in around 11% of the pharmaceutical giant’s 78,400-strong workforce being axed.

Politics

28 h. ago Weight loss drugmaker to slash 9,000 jobs in £926 million cost cut

Novo Nordisk was at one point last year Europe's most valuable listed company

Economics

28 h. ago Wegovy maker Novo Nordisk to cut 9,000 jobs amid increased competition

Danish manufacturer of weight-loss and diabetes drugs under pressure from US rival Eli Lilly Business live – latest newsThe Danish maker of the weight-loss drug Wegovy and diabetes drug Ozempic is to cut 9,000 jobs as it issued a profit warning amid fierce competition from its US rival Eli Lilly.Novo Nordisk’s decision to cut 11% of its global workforce of 78,400 takes place as sales of Wegovy have slowed sharply as it has lost ground to Eli Lilly’s Mounjaro jabs, as well as cheaper versions by generic drugmakers, and the pharmaceutical sector faces the threat of targeted US tariffs. Continue reading...

Politics

30 h. ago Novo Nordisk to cut 9,000 jobs as it slashes profit forecast

Danish drugmaker warns over slowing growth as Ozempic and Wegovy producer faces pressure from US rival Eli Lilly

Politics

30 h. ago Ozempic maker Novo Nordisk to cut 9,000 jobs amid increased competition

Danish manufacturer of weight-loss and diabetes drugs under pressure from US rival Eli Lilly Business live – latest newsThe maker of the weight-loss and diabetes drugs Ozempic and Wegovy is to cut 9,000 jobs as it issued a profit warning amid increased competition from the US rival Eli Lilly.Novo Nordisk’s decision to cut 11% of its global workforce comes as sales of its diabetes drugs including Ozempic have slowed sharply as it faces fierce competition from Eli Lilly’s Mounjaro jabs and the threat of US tariffs. Continue reading...

Politics

4 w. ago Shoe Zone blames Budget tax hikes as chain halves profit forecast

Shoe Zone bosses said they saw weaker ‘discretionary spending’ and decreased footfall in stores.

Economics